We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLOW
501
DELISTED
SPX FLOW, Inc.
FLOW
| $1.51M | 0.03% |
39,279
+32,159
| +452% | +$1.14M |
|
502
Commercial Vehicle Group
CVGI
$157M
| $1.49M | 0.03% |
202,874
-15,400
| -7% | -$112K |
|
503
Lincoln National
LNC
$7.91B
| $1.48M | 0.03% |
20,180
-26,880
| -57% | -$1.9M |
|
|
DRE
504
DELISTED
Duke Realty Corp.
DRE
| $1.48M | 0.03% |
51,280
-330
| -0.6% | -$9.5K |
|
505
Valmont Industries
VMI
$9.44B
| $1.47M | 0.03% |
9,311
+5,760
| +162% | +$868K |
|
506
Daktronics
DAKT
$941M
| $1.47M | 0.03% |
139,100
-37,100
| -21% | -$360K |
|
507
CEVA Inc
CEVA
$1.01B
| $1.47M | 0.03% |
34,292
-12,220
| -26% | -$528K |
|
508
Vornado Realty Trust
VNO
$7.47B
| $1.46M | 0.03% |
+19,000
| New | +$1.45M |
|
509
Rambus
RMBS
$10.4B
| $1.46M | 0.03% |
+109,240
| New | +$1.4M |
|
510
Raymond James Financial
RJF
$32.5B
| $1.46M | 0.03% |
25,875
-21,585
| -45% | -$1.16M |
|
|
HIVE
511
DELISTED
Aerohive Networks
HIVE
| $1.46M | 0.03% |
355,732
+158,970
| +81% | +$638K |
|
|
BMS
512
DELISTED
Bemis
BMS
| $1.45M | 0.03% |
+31,730
| New | +$1.42M |
|
513
Performance Food Group
PFGC
$17.5B
| $1.43M | 0.03% |
50,530
-29,240
| -37% | -$816K |
|
514
InterDigital
IDCC
$6.68B
| $1.42M | 0.03% |
19,305
-78,176
| -80% | -$5.72M |
|
515
Zimmer Biomet
ZBH
$17.7B
| $1.42M | 0.03% |
12,484
+2,843
| +29% | +$328K |
|
|
XENT
516
DELISTED
Intersect ENT, Inc
XENT
| $1.42M | 0.03% |
45,462
+8,950
| +25% | +$265K |
|
|
RTEC
517
DELISTED
Rudolph Technologies Inc
RTEC
| $1.41M | 0.03% |
53,438
-180
| -0.3% | -$4.21K |
|
518
SiriusXM
SIRI
$10B
| $1.4M | 0.03% |
+25,350
| New | +$1.4M |
|
519
Tennant Co
TNC
$1.5B
| $1.4M | 0.03% |
21,074
+17,604
| +507% | +$1.18M |
|
|
TPCO
520
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $1.39M | 0.03% |
95,339
+6,400
| +7% | +$85.6K |
|
|
RST
521
DELISTED
ROSETTA STONE INC
RST
| $1.39M | 0.03% |
135,654
+16,820
| +14% | +$166K |
|
522
Macerich
MAC
$7.32B
| $1.37M | 0.03% |
+24,900
| New | +$1.4M |
|
523
Valvoline
VVV
$4.97B
| $1.37M | 0.03% |
58,283
-2,690
| -4% | -$60.4K |
|
524
MacroGenics
MGNX
$235M
| $1.36M | 0.03% |
73,551
+54,161
| +279% | +$938K |
|
525
Western Alliance Bancorporation
WAL
$9.07B
| $1.35M | 0.03% |
25,420
+15,480
| +156% | +$759K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.